8 completed, 1 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 8, Terminated 1 |
Follow Anidulafungin: new trials by email Literature Review of Anidulafungin trials Research Report on Anidulafungin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) Anidulafungin 100mg single dose iv - Obesity Morbid | Phase 4 | Completed | Radboud University Medical Center | 8 | 2014-08-01 | 2020-12-01 |
| Negative Beta Glucan in ICU Patients Anidulafungin - Candidemia | Phase 4 | Completed | Universidade Federal do Rio de Janeiro | 85 | 2012-11-01 | 2019-07-08 |
| Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients Anidulafungin, Liposomal amphotericin B - Liver Disease, Fungal Infection | Phase 4 | Completed | Fundacion SEIMC-GESIDA | 61 | 2011-11-01 | 2014-05-30 |
| Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations Anidulafungin - Obesity, Mycoses | Phase 4 | Completed | Texas Tech University Health Sciences Center | 20 | 2011-01-01 | 2019-01-09 |
| Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients Anidulafungin, Fluconazole - Mycoses, Fungemia | Phase 4 | Completed | University of Pittsburgh | 200 | 2010-02-01 | 2014-12-17 |
| A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects anidulafungin and voriconazole - Aspergillosis, Candidemia | Phase 4 | Completed | Pfizer | 24 | 2008-09-01 | 2010-02-09 |
| Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) voriconazole, anidulafungin - Aspergillosis | Phase 4 | Terminated | Pfizer | 6 | 2008-08-01 | 2010-02-15 |
| This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Anidulafungin, Voriconazole - Candidemia, Invasive Candidiasis | Phase 4 | Completed | Pfizer | 54 | 2008-02-01 | 2011-01-17 |
| Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) - Candidiasis | Phase 4 | Completed | Pfizer | 282 | 2007-07-01 | 2011-10-03 |
Candidemia (4) · Mycoses (4) · Aspergillosis (2) · Candidiasis, Invasive (2) · Candidiasis (1) · Central Nervous System Fungal Infections (1) · Fungemia (1) · Liver Diseases (1) · Lung Diseases, Fungal (1) · Obesity (1) · Obesity, Morbid (1)
Pfizer (4) · Fundacion SEIMC-GESIDA (1) · Radboud University Medical Center (1) · Texas Tech University Health Sciences Center (1) · Universidade Federal do Rio de Janeiro (1) · University of Pittsburgh (1)
United States (5) · Brazil (2) · Chile (1) · Colombia (1) · Mexico (1) · Netherlands (1) · Panama (1) · South Korea (1) · Spain (1)
Asuncion Moreno, MD (1) · Carlos Cervera, MD (1) · Marcio Nucci, MD (1) · Nina Singh, MD (1) · Ronald Hall, PharmD, MSCS (1)
PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293, PMID 23710653, PMID 24559321, PMID 25376267, PMID 26050015, PMID 27142114, PMID 27287231
5UL1RR024982-02 (1)